DrugPatentWatch Database Preview

CONRAY Drug Profile

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

When do Conray patents expire, and what generic alternatives are available?

Conray is a drug marketed by Liebel-flarsheim and Mallinckrodt and is included in four NDAs.

The generic ingredient in CONRAY is iothalamate sodium. There is one drug master file entry for this compound. Additional details are available on the iothalamate sodium profile page.

Summary for CONRAY

US Patents:	0
Applicants:	2
NDAs:	4
Suppliers / Packagers:	1
Bulk Api Vendors:	11
Patent Applications:	243
Formulation / Manufacturing:	see details
DailyMed Link:	CONRAY at DailyMed

Pharmacology for CONRAY

Drug Class	Radiographic Contrast Agent
Mechanism of Action	X-Ray Contrast Activity

US Patents and Regulatory Information for CONRAY

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Liebel-flarsheim	CONRAY	iothalamate meglumine	INJECTABLE;INJECTION	013295-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes
Mallinckrodt	CONRAY 400	iothalamate sodium	INJECTABLE;INJECTION	014295-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Liebel-flarsheim	CONRAY 30	iothalamate meglumine	INJECTABLE;INJECTION	016983-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes
Mallinckrodt	CONRAY 325	iothalamate sodium	INJECTABLE;INJECTION	017685-001	Approved Prior to Jan 1, 1982		DISCN	No	No

  Purchase this report

or, see our see our flat-rate plans

  Purchase this report

or, see our see our flat-rate plans